Precision Biosciences (DTIL) FCF Margin (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of FCF Margin data on file, last reported at 110.31% in Q1 2026.

• On a quarterly basis, FCF Margin rose 6580694.0% year-over-year to 110.31% in Q1 2026; TTM through Mar 2026 was 130.38%, a 1552.0% decrease from a year earlier, with the FY2025 full-year figure at 192.41%, down 10697.0% from the prior year.
• FCF Margin for Q1 2026 stood at 110.31%, down from 32.95% in the prior quarter.
• Over the last five years, FCF Margin for DTIL reached as high as 381.58% in Q3 2022 and fell as low as 117461.54% in Q3 2025.
• Historically, FCF Margin has averaged 17789.4% across 5 years, with a median of 212.07% in 2022.
• Across the five-year window, FCF Margin slumped 11642838 bps in 2025 and surged 6580694 bps in 2026, its largest moves.
• Year by year, FCF Margin stood at 212.07% in 2022, then surged by 44 bps to 119.31% in 2023, then plunged by 2367 bps to 2943.57% in 2024, then jumped by 99 bps to 32.95% in 2025, then sank by 235 bps to 110.31% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 110.31% in Q1 2026, 32.95% in Q4 2025, and 117461.54% in Q3 2025.